Subscribe to our weekly International update on Health Policies

Equity with Accountability:  What the UN Political Declaration on Pandemic Preparedness Leaves Unresolved

Equity with Accountability:  What the UN Political Declaration on Pandemic Preparedness Leaves Unresolved

On 12 October 2026, the United Nations General Assembly adopted its Political Declaration on Pandemic Prevention, Preparedness and Response (PPPR). The World Health Organization welcomed it as a commitment to sustained investment and international cooperation. Supporters hailed a victory for solidarity and equity. Yet adoption of a non-binding declaration is not agreement on how to deliver its promises. The question is whether it addresses the failures of pandemic governance—or perpetuates them.

A declaration rich in ambitions, short on tests

The Declaration gathers an expansive set of priorities: surveillance, resilient health systems, financing, manufacturing, One Health and access to medical countermeasures. Few are objectionable in isolation. But accumulating worthy aspirations is not a substitute for specifying measurable outcomes, deadlines, responsibilities or consequences for failure. Who will judge whether an additional dollar spent on genomic surveillance saves more lives than the same dollar spent on tuberculosis control, maternal care or sanitation? And who will manage the evidence and control these narratives?

This matters particularly for countries with limited budgets. External financing often comes with donor-selected priorities, reporting obligations, imported programmes and continuing dependence on overseas suppliers. A donor-financed sequencing laboratory may count as national preparedness capacity, while its reagents, software and maintenance remain dependent on external funding. Meanwhile, local health services compete for staff and resources. Equity should not mean transferring authority and predictable income to international intermediaries while leaving national governments responsible for the consequences.

Equity in outcomes, not just commodities

The UN Declaration rightly seeks fairer access to vaccines, diagnostics and treatments. But equal access to a product is not the same as equal improvement in health. Expected benefits differ with age, prior immunity, disease burden and local conditions. As a result, an additional pandemic preparedness measure may be less valuable to a young, relatively low-risk population than malaria prevention or reliable primary care. An equitable system must permit countries to make those comparisons, set their own priorities according to their contextual conditions, and remain answerable to their populations.

The recent Nature Health commentary by Lal and colleagues usefully calls for rebalancing power, reinforcing systems and restoring trust. Yet those ambitions sharpen the test for the UN Declaration. Namely, shouldn’t the objective be to ultimately create sustainable, self-reliant country level systems that address local priorities and hence build health resilience, not consolidate more control centrally at the global level. In other words, the Declaration needs to better reflect more of what has been increasingly recognized by its Member States via other regional and multilateral efforts, as well as the growing aim of increasing local capacities articulated in such initiatives as the Accra Reset and the African CDC’s expanded remit? If so, then which of the usual global institutions (and new ones like the Pandemic Fund) and their NGO proxies have the incentive to surrender existing authority, through what mechanisms, and how will mistakes be corrected when they don’t? In other words, how exactly is the UN Declaration addressing long-standing dependency cycles and imbalances in power? Trust is not restored through more inclusive language alone. It requires transparency, admission of errors when they occur, credible limits on power, and the rebalancing of ownership.

Accountability after COVID-19

COVID-19 revealed the need to distinguish harm caused by the pathogen from harm caused by policy responses. School closures, movement restrictions, disruptions to routine care and uniform interventions had unequal consequences across societies. The UN Declaration does not provide a convincing framework for independently reviewing these trade-offs or correcting poorly performing approaches. It hints to entrench the same biomedical and securitized health approaches pursued in the past, which have skewed public health away from social determinants, primary care, and health system strengthening. Preparedness spending should be evaluated against actual health benefits, including opportunity costs—not just the number of new plans, laboratories, market commitments embedded, or exercises funded.

The same scrutiny should apply to the current financial case for preparedness. The   WHO–World Bank estimate of US$31.1 billion in annual spending ( with a total national investment expenditure target of 26.4 for PPPR disproportionately shouldered by already squeezed Low-and Middle income countries)   has been challenged by researchers examining its underlying assumptions and projected returns. This criticism of poor evidence and modelling does not prove preparedness is unnecessary, a level of preparedness is indeed prudent. Yet, it does mean that financing targets, beneficiaries and alternatives deserve independent examination before becoming enduring health security obligations, especially when those obligations have  a proven track record of redirecting funds away from existing health priorities.

Political endorsement is not a settled bargain

The declaration is distinct from the WHO Pandemic Agreement, the amended International Health Regulations and the still-unresolved pathogen access and benefit-sharing (PABS) negotiations. Its endorsement cannot settle disputes over access to data, reciprocal access to products, intellectual property, financing or sovereignty. Countries asked to share pathogen materials and data reasonably want enforceable assurances about the benefits they will receive. Calling this solidarity does not resolve the underlying bargain or address the long-standing structural inequities in global health policies that drive that ‘bargain’.

What equity with accountability requires

A more credible UN Declaration would insist on independent review of pandemic interventions, transparent tracking of funds from donor to contractor, and published comparisons of preparedness spending with competing health priorities. It would protect national discretion, define reciprocal obligations clearly and favour sustainable local capacity over permanent donor dependence. International cooperation should support national responsibility, not displace it.

The UN Declaration recognizes real weaknesses in global health. But recognizing them is not the same as repairing the incentives that (re)produced them. Equity with accountability means judging institutions by improved health, exposing errors and returning decisions to the people who bear their consequences. Without those tests, solidarity risks becoming another promise made in New York and paid for elsewhere.

About Garrett Wallace Brown

Garrett Wallace Brown is Chair of Global Health Policy at the University of Leeds, UK. His research focuses on global health governance, health financing, health system strengthening, health equity and health emergency preparedness and response. He has conducted policy and research collaborations in global health for over 25 years and has worked with NGOs, governments in Africa, the UK Cabinet Office, World Health Organization, G7 and G20.

About Roger Bate

Roger Bate is president of the Center for Global Health Accountability and a nonresident scholar at the International Center for Law & Economics. A health economist with a PhD from the University of Cambridge, his research focuses on global health governance, regulatory accountability, and the effects of public policy on health outcomes.

About David Bell

David Bell is a clinical and public health physician with a PhD in population health and background in internal medicine, modelling and epidemiology of infectious disease. Previously, he coordinated malaria diagnostics as a medical and scientific officer at the World Health Organization, was Programme Head of malaria and acute febrile illness at FIND in Geneva, and Director of Global Health Technologies at Intellectual Ventures Global Good Fund in the USA. He currently consults in biotech and international public health.

About Ramesh Thakur

Emeritus professor in the Crawford School of Public Policy, Australian National University, a former United Nations Assistant Secretary-General under Kofi Annan, and Fellow of the Australian Institute of International Affairs. His books include Global Governance and the UN, The Oxford Handbook of Modern Diplomacy, The United Nations, Peace and Security, and The Nuclear Ban Treaty.
add a comment

Your email address will not be published. Required fields are marked *

0 comments